Pharmaceutical Executive
Positioning for success in biopharma requires a self-critical analysis of the risk and rewards among four categories of value differentiation. The key question: How do you define yourself against the competition?
Jo Pisani
Advertisement
Articles by Jo Pisani
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pharma M&A Roundup: Novartis to Acquire Pan-Mutant-Selective PI3Kα Inhibitor from Synnovation Therapeutics, Collegium to Acquire Azstarys from Corium Therapeutics
2
Pharmaceutical Executive Daily: FDA Approves Wegovy HD
3
FDA Approves Wegovy HD Injectable Under Accelerated Approval
4
What Pharma Marketers Need to Know About Recent Gartner Predictions About AI and What It Means to Them
5